Precipio Logo

Scientific Advisory Board

Jeffrey Sklar, MD, PhD

Dr. Sklar is a tenured faculty at Yale University. He holds a BA from Haverford College, an MD and Ph.D. from Yale University. He also completed a Post-doctorate fellowship in Biochemistry at Stanford University, and holds an MA from Harvard University. Dr. Sklar is a pioneer and one of the world leading thinkers in the area of molecular genetics. He has developed several tests that are

currently part of a standard protocol of testing within pathology diagnostics laboratories (by manofsky). In his work at the Yale Cancer Center, Dr. Sklar has been one of the leaders in the area of personalized medicine research, and the development of new tests and panels to help link tumor genetic composition to drug efficacy. Dr. Sklar's contribution will be in the development of new molecular tests under Precipio's umbrella.

 

Gil Mor Image

Gil Mor, MD, PhD

Gil Mor, MD, PhD is a tenured Professor of Obstetrics and Gynecology and Reproductive Science at Yale University School of Medicine. He is the Division Director of the Reproductive Science Division at the Department of Obstetrics and Gynecology.  He directs the Reproductive Immunology Unit and the Translational  Research Program “Discovery To Cure” at Yale University.

Dr. Mor has been the Editor in Chief of the American Journal of Reproductive Immunology since September 2009 and is the President Elect of the American Society for Reproductive Immunology. Dr. Mor earned his PhD in Immunoendocrinology from the Weizmann Institute of Science and his MS and MD from Hebrew University in Jerusalem.

 

 

David Hudnall, MD

S. David Hudnall, MD is Professor of Pathology and Laboratory Medicine, and Director of Hematopathology at Yale University School of Medicine. Dr. Hudnall attended medical school at the Medical University of South Carolina in Charleston, SC (1974-78). Following his medical training, Dr. Hudnall completed his residency in Anatomic and Clinical Pathology at the Yale-New Haven

Hospital, Yale University School of Medicine (1978-82). This training was followed by a Research Fellowship in Pathology (1982-84) at the Brigham and Women's Hospital, at Harvard Medical School. Dr. Hudnall held academic positions in Pathology at UCLA, Baylor, and the University of Texas Medical Branch before returning to New Haven in 2009 to serve as Professor and Director of Hematopathology. Dr. Hudnall is board-certified in Anatomic Pathology, Clinical Pathology, and Hematology (Pathology). He has authored more than 130 peer-reviewed articles, book chapters, and abstracts on a wide variety of topics in hematopathology, and is the recipient of numerous teaching awards. Based upon his 26 years of experience in the practice and teaching of all aspects of hematopathology, Dr. Hudnall has recently published a new single-authored text entitled Hematology: A Pathophysiologic Approach (2011, Mosby/Elsevier). Other interests include long distance running, hiking, vegetable gardening, philosophy, and mathematics.

Mike Markrigiorgos Image

Mike Makrigiorgos, PhD

Dr. Makrigiorgos is a Professor of Radiation Oncology and Director of the Medical Physics & Biophysics division at Dana Farber Cancer Institute and Brigham and Women’s Hospitals, Harvard Medical School.  He is the inventor of several PCR-based techniques for molecular diagnostics, including Balanced-PCR, NaME-PrO technology and COLD-PCR.  He is a Member of the Editorial Board of

Clinical Chemistry and has published over 150 articles, reviews and book chapters.  Dr. Makrigiorgos received his PhD in Medical Physics from the University of Leeds, UK and his postdoctoral training in radiation biology from Harvard Medical School, Boston.

 

Gil Mor Image

Mahul Amin, MD

Dr. Amin is the Professor and Chair of the Department of Pathology and Laboratory Medicine, Professor of Urology and the Gerwin Endowed Chair for Cancer Research at University of Tennessee Health Sciences Centre; he conducts his clinical practice as the Chief of Pathology at Methodist University Hospital, Memphis, TN. Dr. Amin co-authored the 2002 World Health Organization (WHO)

classification systems for urothelial tumors and renal neoplasms (authored 7 chapters); and the 2016 WHO classification systems for tumors of the prostate, bladder, kidney, penis and testis (authored 21 chapters). Dr. Amin earned his MD at G.S. Medical College and King Edward Memorial Hospital in Bombay, India.

CONNECT WITH PRECIPIO:

Facebook Icon Linkedin Icon Twitter Icon

© 2017 Precipio, All Rights Reserved